Pfizer and BioNTech’s updated COVID-19 vaccine targeting the KP.2 strain, a descendant of JN.1, has been recommended by the ...
Wherever you sit in the partnership triangle, does it sound familiar? Many initiatives have tried to address this partnership ...
Picture this: a medicine targeting a particular disease is developed over 12-15 years from initial candidate selection, ...
The US Food and Drug Administration (FDA) has approved Zevra Therapeutics’ Miplyffa (arimoclomol) to treat Niemann-Pick ...
Sanofi has shared positive results from a late-stage study of its investigational BTK inhibitor, tolebrutinib, in patients ...
Merck & Co – known as MSD outside the US and Canada – has shared positive overall survival (OS) results from a late-stage ...
LEO Pharma’s Anzupgo (delgocitinib) cream has been approved by the European Commission (EC) to treat adults with ...
The essence of omnichannel marketing is to ensure that your messaging is reaching your target audience where they spend most ...
The European Commission (EC) has extended the marketing authorisation for Bavarian Nordic’s smallpox and mpox vaccine to ...
Novo Nordisk and NanoVation Therapeutics have entered into a multi-year partnership worth $600m to advance genetic medicines ...
Daiichi Sankyo’s Vanflyta (quizartinib) has been recommended by the National Institute for Health and Care Excellence (NICE) for certain cases of acute myeloid leukaemia (AML). The drug has been ...
Roche’s injectable PD-L1 inhibitor Tecentriq Hybreza (atezolizumab and hyaluronidase-tqjs) has been approved by the US Food and Drug Administration (FDA) for multiple cancer types. The subcutaneous ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback